Micron sells memory. Funny, because nobody remembers buying it at $285 😅 $MU in 2026: up 225.4% Now worth $1.05 trillion. The best part? It still trades at 12.5x earnings. Forward P/E: 4.5x on next year's estimates. A trillion dollar stock priced like it might forget what it does. Too cheap to ignore, or the market forgot something? 👇

Same drug race. Opposite results 👀 $LLY in 2026: up 19.3% $NVO in 2026: down 24.0% Lilly is now worth $1.14T. Novo is worth $171B. That's almost 7x bigger. The twist? Novo trades at 9.6x earnings. Lilly trades at 43x. Lilly reports tomorrow, Oct 29. Novo reports Nov 4. Cheap for a reason, or the bargain of the year? 👇

Boring oil stocks are crushing Nvidia this year 🛢️🤯 2026 so far: 1. $COP up 58.1% 2. $CVX up 49.7% 3. $XOM up 49.5% 4. $SHEL up 42.6% $NVDA? Up 16.9%. And the real winner isn't even American. $EQNR is up 99.2% 🤯 Cheapest by P/E: $SHEL 11.6x • $COP 19.6x • $CVX 22.0x • $XOM 23.2x $XOM and $CVX report Friday morning before the open. Still time to buy, or is the oil trade done? 👇

$NVDA powered the AI boom. Then 4 chip stocks left it behind 😅 The 6 biggest chip stocks listed in the US before 2026: 1. $MU up 225.4% 2. $AMD up 161.6% 3. $INTC up 154.0% 4. $TSM up 43.8% 5. $NVDA up 16.9% 6. $AVGO down 1.1% (Not counted: equipment makers like $ASML, or $SKHY, which only listed in July) $NVDA is still worth $5.26 trillion, more than $TSM and $AVGO combined. But $INTC stock's gain this year is 9x $NVDA's. Micron, AMD and Intel ran. The AI king walked. AI king or comeback kids, who wins 2027? 👇

Everyone's talking about Tesla's flying car 🚗✈️ Well.. the chart is ready to take off 🚀 $TSLA weekly trendline break 👀 🔹 A falling line from the $498.83 high in December (also the all time high) through the $453.40 high in May has capped every week for 10 months 🔹 This week it pushed through and closed yesterday at $407.46, up 9.5% so far this week 🔹 Back over the 20 day, 50 day and 200 day averages 📊 Revenue over the last 12 months $103.57B, net income $3.22B 💰 Free cash flow $3.30B over the last 12 months, at over 400x earnings ⚠️ The week isn't done. If Friday's weekly close is under $398.90, the setup is off. First test is $421.88, the 61.8% retrace of the drop from the high. Q3 operating income also fell 56% as AI and Optimus spending rose ✅ Confirm: weekly close over $398.90 🟢 TP1 $431.20 (+8.1%) • TP2 $453.40 (+13.7%) • TP3 $498.83 (+25.1%) ⛔ Invalid: daily close under $392.92 (down 1.5%) Risk from the $407.46 close to Invalid is about 3.6%, and TP1 pays about 1.6x. Please respect your SL level 🙏

$URBN bull flag 👀 Urban Outfitters, the clothing and home brand behind Urban Outfitters, Anthropologie and Free People. 🔹 Ran from $74.10 to $90.59 in three weeks (Sep 25 to Oct 16) 🔹 Then rested in a tight flag between $85.43 and $90.59 🔹 Yesterday it closed at $90.73, an all time high close, and above the 20 day, 50 day and 200 day averages 📊 Q2 net sales a record $1.66B, adjusted EPS $1.72, the eighth straight quarter of record sales and profits 💰 Retail comparable sales up 6.2%, Free People comps up 10.0%, subscription sales up 28.6% 📈 Net income of $356.4M and EPS of $4.06 over the first six months ⚠️ The close is only a hair over $90.59, so a slip back under it weakens the setup. Volume on the breakout was only about 1.2x normal, and Q2 adjusted EPS of $1.72 was a penny under the $1.73 consensus ✅ Confirmed: daily close over $90.59 🟢 TP1 $101.92 (+12.5%) • TP2 $107.08 (+18.2%) • TP3 $123.85 (+36.7%) ⛔ Invalid: daily close under $89.23 (down 1.5%) Risk from the $90.73 close to Invalid is about 1.7%, and TP1 pays about 7.5x. Please respect your SL level 🙏

$BDC trendline breakout 👀 Belden, maker of networking, cable and industrial connectivity gear. 🔹 Since the August high near $140, every bounce made a lower high along one falling line 🔹 Yesterday it closed at $107.48, over that line at $105.98 📊 Q2 revenue a record $750M (up 12%), adjusted EPS $2.34 (up 24%), record orders of $836M with a book to bill of 1.11 💰 Q3 guide: revenue $950M to $970M including RUCKUS, adjusted EPS $2.15 to $2.30 📈 The RUCKUS acquisition closed Jul 1, and AI data center demand is starting to show in the order book ⚠️ Results come tomorrow, Oct 29 before the open, with the Street at $2.26 EPS on $962M of revenue, and Q2 EPS included a $0.25 tariff recovery benefit. The 50 day near $112.63 is a wall before TP1, and TP1 sits on the 200 day at $118.30 ✅ Confirmed: daily close over $105.98 🟢 TP1 $118.30 (+11.6%) • TP2 $125.27 (+18.2%) • TP3 $140.19 (+32.3%) ⛔ Invalid: daily close under $100.83 (down 4.9%) Risk from the $107.48 close to Invalid is about 6.2%, and TP1 pays about 1.6x. Please respect your SL level 🙏

$RL triangle breakout 👀 Ralph Lauren, the clothing and lifestyle brand. 🔹 22 weeks squeezing inside a triangle, lower highs on top and higher lows below 🔹 Yesterday it closed at $391.25, over the falling line at $388.34 🔹 Back over the 20 day, 50 day and 200 day averages 📊 Q1 revenue up 14% (13% in constant currency), adjusted EPS $4.59 (up 22%), with Asia up 24% and North America up 13% 💰 FY27 outlook raised: constant currency revenue growth of about 5% to 6%, with more than $300M returned to shareholders in Q1 📈 Direct-to-consumer comparable store sales up low double digits, with average selling prices up 15% ⚠️ Old highs at $419.38 to $421.60 sit between TP1 and TP2, so expect sellers there. Volume was only about average, and results come Thursday, Nov 5 before the open ✅ Confirmed: daily close over $388.34 🟢 TP1 $410.02 (+5.6%) • TP2 $443.70 (+14.3%) • TP3 $477.73 (+23.0%) ⛔ Invalid: daily close under $382.52 (down 1.5%) Risk from the $391.25 close to Invalid is about 2.2%, and TP1 pays about 2.2x. Please respect your SL level 🙏

Buy or Bye? 🤔 $MRK Merck ran up 77% from its 52 week low of $82.01 and now sits 7% under its all time high of $156.92. Too late or still a buy? Read to the end for my verdict 🟢🔴 💰 Why it's worth a look • Free cash flow $16.06B over the last 12 months, about 4.5% of the market cap • Dividend yield about 2.3% • Q2 free cash flow $4.48B, up 77% • Market cap about $358B 🚀 What's working • Q2 sales $16.61B, up 5%. Keytruda $8.4B, up 5% • Merck and Moderna cancer vaccine plus Keytruda cut melanoma recurrence or death risk by 42% in Phase 3 (Oct 22) • Europe approved Keytruda plus Padcev for bladder cancer (Oct 21) • 21 of 31 analysts rate it Buy • Analyst average target $158.84 😬 What the market fears • Net loss in Q1 and Q2 2026 from one time deal charges (Cidara $9.0B, Terns $5.7B), so trailing P/E is about 116x • EV/EBITDA about 21x, not cheap • Total debt $53.9B, up 52% in a year • Keytruda, its biggest drug, loses US patent protection in 2028 • A Dutch court blocked the new Keytruda shot in 8 European countries on Oct 7 in a patent fight with Halozyme • Q3 results due Oct 29 📍 The investment plan Don't chase it at $145. 2 buys with limit orders, the bigger one lower: 1️⃣ $138 to $141 2️⃣ $124 to $128 Average entry about $131.45. ⛔️ Exit on a weekly close under $119. 🎯 Scenarios from my average entry Bear $119 break: down 9% Base $156.92 (all time high): up 19% Bull $179.66: up 37% ✅ My verdict: BUY on the dip 🟢 Not financial advice Buy or bye? Tell me 👇

In 2013, $TSLA was weeks from running out of cash. Elon called Larry Page and offered to sell Tesla to $GOOGL for about $6 billion. Page reportedly shook on it 🤝 Then Tesla employees started calling every customer to deliver cars. Sales came back. The deal died. Tesla today: about $1.47 trillion. Roughly 245x that price. If you were Elon, would you have taken the $6B?

In March 2000, $CSCO was the most valuable company on earth 🧠 It closed at $80.06 on Mar 27, 2000. 2 years later it was down 89%. It didn't close above $80.06 again until Dec 10, 2025. 25 years and 8 months to get back to even. And sales more than tripled in that time. Today $NVDA is the biggest company in the world at $5.36T. Is $NVDA the next $CSCO, or is this time different?

POV YOU FINALLY BOUGHT THE DIP

I gave you: $AAOI $110 → $69 $UCTT $76 → $44 $FPS $40 → $24 $ICHR $59 → $37 $ACMR $76 → $49 $ALAB $377 → $261 My best work. Zero likes 🫠 Give me one good reason you're not following me yet? 🧐

Gold has beaten the S&P 500 since 2000. Even with dividends 🪙 $10,000 invested in Aug 2000: Gold: $151,515 (up 1,415%) S&P 500 with dividends reinvested ($SPY): $81,865 (up 719%) 26 years of "stocks always win," and gold made almost double the gain. Team gold or team stocks?

I try to like every post I see and reply to a lot of them. If I follow you, you've probably seen me in your replies on daily basis 🤝 I have over 1,000 followers, and most days the same 3 people show up in mine. I can't be thankful enough for everyone who supports me cause I put so much effort into my posts 💚 A like costs nothing. A reply means a lot more. If my posts aren't for you, no hard feelings. Unfollow and I'll do the same. If they are, what's one thing you want me to post more of? Drop 1, 2 or 3 in the comments section 👇 1- Swing setups 2- Investment Ideas 3- Market Insights

$NVDA is now worth more than 2x the 9 biggest oil producers in the US and Europe combined 🤯 $XOM, $CVX, $SHEL, $TTE, $COP, $BP, $EQNR, $E and $EOG together: $2.26T $NVDA alone: $5.36T 🤑 It also made more profit in the last year than all 9 of them put together. The world still runs on oil. Is the market right, or is this a bubble?

Boring stocks are crushing $NVDA this year 🏗️ 2026 so far: $NUE (steel): up 62.2% $MRK (medicine): up 42.4% $DE (tractors): up 36.7% $FAST (screws and bolts): up 30.8% $CAT (bulldozers): up 29.2% $JNJ (medicine): up 24.6% $NVDA (AI chips): up 19.0% Everyone chased AI. Steel won. Will boring keep winning, or will $NVDA take over from here?

Same stock. Two charts 🔍 $TSLA this year: down 14.1% 🔴 $TSLA last 10 years: up 2,797% 🟢 $10,000 in Oct 2016 is about $290,000 today. Would you buy TESLA today for the next 10?